| Literature DB >> 31582842 |
Roberta Noberini1, Tiziana Bonaldi2.
Abstract
The identification of the full target spectrum of active molecules, known as target deconvolution, has become an indispensable step during the drug discovery process. It is now achievable thanks to mass spectrometry-based technologies. Here we discuss these approaches in the context of epigenetic drug discovery.Mesh：
Substances：
Year: 2019 PMID： 31582842 DOI： 10.1038/s41594-019-0279-x
Source DB: PubMed Journal: Nat Struct Mol Biol ISSN： 1545-9985 Impact factor: 15.369